相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
A. B. Schrock et al.
ANNALS OF ONCOLOGY (2019)
Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial
Benedito A. Carneiro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Lawrence A. Donehower et al.
CELL REPORTS (2019)
Association Between Tumor Mutation Burden (TMB) and Outcomes of Cancer Patients Treated With PD-1/PD-L1 Inhibitions: A Meta-Analysis
Jiaxin Zhu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
Mouhammed Amir Habra et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer
Lia Head et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes
G. J. Ortiz et al.
ONCOGENE (2018)
Advances in therapeutic targeting of the DNA damage response in cancer
Amar Desai et al.
DNA REPAIR (2018)
Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab
R. T. Casey et al.
SEMINARS IN ONCOLOGY (2018)
β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion
Shenghua Liu et al.
ONCOTARGETS AND THERAPY (2018)
Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survival
Rajani Maharjan et al.
SCIENTIFIC REPORTS (2018)
Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors
Sudheer Kumar Gara et al.
NATURE COMMUNICATIONS (2018)
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Siyuan Zheng et al.
CANCER CELL (2016)
Genomic landscape of DNA repair genes in cancer
Young Kwang Chae et al.
ONCOTARGET (2016)
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
Martin Fassnacht et al.
LANCET ONCOLOGY (2015)
Adrenocortical Carcinoma
Tobias Else et al.
ENDOCRINE REVIEWS (2014)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Martin Fassnacht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Adrenocortical Carcinoma in the United States Treatment Utilization and Prognostic Factors
Karl Y. Bilimoria et al.
CANCER (2008)
Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress?
E Kebebew et al.
WORLD JOURNAL OF SURGERY (2006)
Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial
A Berruti et al.
ENDOCRINE-RELATED CANCER (2005)
分享论文
